Lymphoma Clinical Trials in North Carolina

Showing 641-647 of 647 trials

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

NCT00105313

For primary objectives, we will determine the MTD and examine clinical responses and immune cell populations to determine an OBD, and describe the safety and tolerability of MEDI-507. For the secondary objectives we will look at the antitumor activity of MEDI 507, PK, serum concentrations, and immunogenicity of MEDI-507, as well as time courses of depletion and recovery of CD2 positive and total T-Cell populations.

LymphomaLeukemiaCancer

MedImmune LLC80 participantsStarted Feb 2005

Los Angeles, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +8 more locations

COMPLETEDPhase 1/257 miles

Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab

NCT00062894

The purpose of this study is to assess the blood pharmacokinetics in patients with previously untreated or relapsed follicular or transformed follicular non-Hodgkin's lymphoma who have received a dosimetric dose of fission-derived iodine I 131 tositumomab.

Non-Hodgkin's Lymphoma

GlaxoSmithKline12 participantsStarted Apr 2003

Bay Pines, Florida, United States • Chicago, Illinois, United States • Ann Arbor, Michigan, United States +3 more locations

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab

Lymphoma Trials in Other Cities

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Other Conditions in North Carolina